Building on these concepts, several commercial ventures are advancing metal-binding protein technologies from laboratory prototypes toward practical deployment
In the case of AFs, however, it is worthy to point out this fact that the elimination of these mycotoxins in food/feed is impossible, leading to the continuous existence of these risk factors in the environment
In February 2026, Novo Nordisk announced that the US Food and Drug Administration has approved Ozempic tablets, an oral form of semaglutide, with availability expected in the United States in the second quarter of 2026
doi:10.3389/fendo.2024.1309118 24
Weight Loss Results: Head-to-Head Data Semaglutide Clinical Trial Results The STEP (Semaglutide Treatment Effect in People with Obesity) trial program is the most comprehensive dataset for any anti-obesity medication: STEP 1 (Wilding et al., 2021, NEJM ): 1,961 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Semaglutide 2.4 mg weekly vs